PhnyX Lab Secures $4 Million in Seed Funding Led by SK Networks

August 04, 2025
PhnyX Lab has raised $4 million in a seed funding round led by SK Networks, with participation from notable investors like Aidan Gomez and Illia Polosukhin.

PhnyX Lab has successfully closed a $4 million seed funding round, announced in a press release. The round was led by SK Networks, with participation from prominent angel investors including Aidan Gomez, co-founder and CEO of Cohere, and Illia Polosukhin, co-founder of NEAR Protocol.

The funding will support the expansion of PhnyX Lab's flagship platform, Cheiron, which launched in December 2024. Cheiron is already utilized by over 60 companies, including Korea's top 10 pharmaceutical firms, to streamline complex workflows such as research paper and clinical trial searches. Building on this momentum, PhnyX Lab is expanding Cheiron into a broader product suite, including Cheiron Write, designed to automate medical writing processes.

This investment marks a significant milestone for PhnyX Lab as it aims to transform manual pharmaceutical processes into intelligent, integrated workflows, enhancing efficiency in drug discovery and approval processes.

We hope you enjoyed this article.

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more